World Leaders in Human Research Ethics Launch CyberMedica

Greg Koski, Ph.D., M.D. C.P.I.
Chairman of the Board and Co-Founder
The CyberMedica Foundation
http://www.CyberMedica.org
Senior Scientist, Institute for Health Policy
Associate Professor of Anesthesia, Massachusetts General Hospital, Harvard Medical School
Former Director, Office for Human Research Protections [OHRP], U.S. Department of Health and Human Services [DHHS] Co-Founder of The CyberMedica Foundation http://www.CyberMedica.org

CyberMedica Suite -

POWERFUL REGULATORY COMPLIANCE SOFTWARE WITH UNRESTRICTED REDISTRIBUTION RIGHTS, DELIVERING THE CULTURE OF CONSCIOUSNESS AND FASTER CURES TODAY

The CyberMedica Foundation has philanthropically gifted open source licenses to all of it's software, source code, training materials and documentation. To date over $15 million dollars has been invested in the peer-reviewed creation and development of CyberMedica's auditable modern eR&D framework including both it's secure internet centric software platform and technical infrastructure architecture.

CyberMedica's making it's complete system availaible at no cost and without restriction to any institution as a catalyst to promote better health through responsible human research globally. Our goal is to speed discovery by an order of magnitude by gifting our unified platform for ethical management oversight of the entire clinical trial protocol process.

CyberMedica's goal is to saves lives and speed cures to market by giving away open standard core informatics tools to organizations world wide catalyzing rapid pervasive ubitquious deployment and vastly improving clinical efficacy in a culture of consciousness. We need your support!

CyberMedica's software suite will increase the effectiveness of any institution, reduce administrative overhead, decrease overall liability, help ensure compliance, identify procedural and personnel bottlenecks, streamline the creation, workflow and handling of new protocols, funding requests, approvals, trials, regulatory reporting, including documentation, minutes, adverse events reporting and continuing reviews and ultimately provide a new standard of quality and efficiency in the peer-review publishing of outcomes speeding solutions to market.